Literature DB >> 2887769

Coagulation factors and the progress of coronary heart disease.

L Balleisen, H Schulte, G Assmann, P H Epping, J van de Loo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887769     DOI： 10.1016/s0140-6736(87)91004-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Modelling the Helsinki Heart Study by means of risk equations obtained from the PROCAM Study and the Framingham Heart Study.

Authors:  G Assmann; H Schulte
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers.

Authors:  A E Thomas; F R Green; H Lamlum; S E Humphries
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

3.  Does weight loss reduce plasma fibrinogen?

Authors:  E Ernst
Journal:  Br Heart J       Date:  1993-08

Review 4.  How it all starts: Initiation of the clotting cascade.

Authors:  Stephanie A Smith; Richard J Travers; James H Morrissey
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-05-28       Impact factor: 8.250

5.  Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia.

Authors:  C Otto; K G Parhofer; M M Ritter; W O Richter; P Schwandt
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

6.  Factor VIII and coronary heart disease.

Authors:  F R Rosendaal
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.